KPTI vs AGFY Comparison

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.